New answer by Medical Oncologist at University of Washington School of Medicine (February 17, 2025)
Currently, I am not using NIAGARA trial data for patients with upper tract urothelial carcinoma (since it was only for MIBC), but am very enthusiastic about the ongoing EA8192...